Thursday, 16 May 2013

Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2013
May 15th 2013, 00:00

BMI View: The risks of investing in C?te d''Ivoire''s pharmaceutical and healthcare industry arenumerous. Politically, the country is in a fragile state, with concerns over security commonplace.Economically, C?te d''Ivoire posts a better performance, but there are many challenges to doing business inthe country, not least the presence of substandard drugs, lack of trained healthcare personnel, weak IPframework and supply chain concerns (such as a lack of suitable storage facilities in rural areas). Domesticdrug production - essential to reduce the government''s expensive import bill - is limited; only a fewmanufacturing facilities exist, mainly for the production of e...

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment